NCT05105919View on ClinicalTrials.gov

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 26, 2021

Primary Completion Date

April 1, 2024

Study Completion Date

July 1, 2024

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Aspirin 80 mg EC Tab

Participants will receive a 7 day supply of Aspirin 80 mg EC Tab and will be instructed to take the drug at the same time every day for 7 days.

Trial Locations (1)

H1T 1C8

RECRUITING

Montreal Heart Institute, Montreal

All Listed Sponsors
collaborator

Institut de Recherches Cliniques de Montreal

OTHER

lead

Montreal Heart Institute

OTHER